230 related articles for article (PubMed ID: 31638886)
1. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
2. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease.
Quek DT; Jap A; Chee SP
Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937
[TBL] [Abstract][Full Text] [Related]
7. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes of Uveitis Associated with Vogt-Koyanagi-Harada Disease in the Pediatric Age Group.
AlBloushi AF; AlEnezi SH; Al Owaifeer AM; Al-Hadlaq OS; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2022; 30(7-8):1669-1677. PubMed ID: 34184966
[TBL] [Abstract][Full Text] [Related]
10. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
[TBL] [Abstract][Full Text] [Related]
11. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
12. Cataract surgery in patients with Vogt-Koyanagi-Harada syndrome.
Ganesh SK; Padmaja ; Babu K; Biswas J
J Cataract Refract Surg; 2004 Jan; 30(1):95-100. PubMed ID: 14967274
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
Alvarez-Guzman C; Valdez-Garcia JE; Ruiz-Lozano RE; Rodriguez-Garcia A; Navas-Villar CF; Hartleben-Matkin C; Pedroza-Seres M
Int Ophthalmol; 2022 Dec; 42(12):3913-3921. PubMed ID: 35789316
[TBL] [Abstract][Full Text] [Related]
15. Complications and prognostic factors in Vogt-Koyanagi-Harada disease.
Read RW; Rechodouni A; Butani N; Johnston R; LaBree LD; Smith RE; Rao NA
Am J Ophthalmol; 2001 May; 131(5):599-606. PubMed ID: 11336934
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
18. Vogt-Koyanagi-Harada disease in Thailand.
Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
[TBL] [Abstract][Full Text] [Related]
19. Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease.
Yoshitomi S; Harada Y; Hiyama T; Yuasa Y; Hirooka K; Kiuchi Y
Int Ophthalmol; 2023 Aug; 43(8):2857-2866. PubMed ID: 36929369
[TBL] [Abstract][Full Text] [Related]
20. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome.
Moorthy RS; Rajeev B; Smith RE; Rao NA
Am J Ophthalmol; 1994 Aug; 118(2):197-204. PubMed ID: 8053465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
